⌘K

Login Start Free

Home/Filings/4/0001144204-19-036592

4//SEC Filing

Gaston-Dreyfus Remi 4

Accession 0001144204-19-036592

CIK 0001508381other

View on SEC.gov Company Profile

Filed

Jul 29, 8:00 PM ET

Accepted

Jul 30, 12:04 PM ET

Size

5.3 KB

Accession

0001144204-19-036592

Insider Transaction Report

Form 4

Period: 2019-07-26

Bionik Laboratories Corp.BNKL

Gaston-Dreyfus Remi

Director

Transactions

Award
Employee Stock Option (right to buy)
2019-07-26+115,759→ 115,759 total
Exercise: $3.59From: 2020-07-26Exp: 2026-07-26→ Common Stock, par value $0.001 (115,759 underlying)

Documents

1 file

4
tv526213_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Bionik Laboratories Corp.

CIK 0001508381

Entity typeother

Related Parties

1

filerCIK 0001716639

Filing Metadata

Form type: 4
Filed: Jul 29, 8:00 PM ET
Accepted: Jul 30, 12:04 PM ET
Size: 5.3 KB

View on SEC.gov